Month: January 2025

Performance HighlightsNet Income: Net income for the quarter ended December 31, 2024, was $2.0 million or $0.19 per share, compared to $919 thousand or $0.09 per share, recorded in the prior linked quarter and $1.3 million or $0.12 per share, in the comparable 2023 quarter. Cash Net Income: Cash net income for the quarter ended December 31, 2024, was $2.2 million or $0.21 per share, compared to $1.9 million or $0.18 per share, recorded in the prior quarter and $1.5 million or $0.14 per share, in the comparable 2023 quarter Significant Non-Interest Income Growth: Due to an increase in loan sale volume and loan sale premiums received for the quarter ended December 31, 2024, non-interest income increased by $1.0 million or 53.4% from the prior linked quarter and were up $1.5 million or 106.6% from the prior year quarter. Net Interest Income:...

Company Notes Continued Concerns Regarding Liquidity and Consideration of Potential Ways to Address Operational and Financial Challenges SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe,” the “Company,” “we,” “us,” and “our”), a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, reported its financial results for the third quarter (“Q3”) of fiscal year 2025 (“FY25”), which ended December 31, 2024. Notable Items in Q3 of FY25We recognized $19.3 million of non-recurring research services revenue pursuant to the 2023 GSK Amendment. This revenue represents substantially all remaining revenue associated with the 2023 GSK Amendment. We received the cash associated with this revenue in Q3 of FY24. Consumer Services Revenue...

Sales of $405 million, down 14 percent from the prior-year quarter Previously announced carboxymethylcellulose (CMC), methylcellulose (MC) and nutraceuticals portfolio optimization initiatives (collectively, “Portfolio Optimization”) reduced overall sales by approximately $50 million or 11 percent versus the prior-year quarter. Excluding Portfolio Optimization, sales declined 3 percent versus prior-year quarter Loss from continuing operations of $166 million, or loss of $3.51 per diluted share Adjusted income from continuing operations excluding intangibles amortization expense of                $14 million, or $0.28 per diluted share Net loss of $165 million, or loss of $3.50 per diluted share Adjusted EBITDA of $61 million, down 13 percent from the prior-year quarter. Portfolio Optimization reduced overall Adjusted EBITDA by approximately...

TUPELO, Miss., Jan. 28, 2025 (GLOBE NEWSWIRE) — Renasant Corporation (NYSE: RNST) (the “Company”) today announced earnings results for the fourth quarter of 2024.(Dollars in thousands, except earnings per share) Three Months Ended   Twelve Months Ended  Dec 31, 2024 Sep 30, 2024 Dec 31, 2023   Dec 31, 2024 Dec 31, 2023Net income and earnings per share:            Net income $ 44,747 $ 72,455 $ 28,124     $ 195,457 $ 144,678  After-tax gain on sale of insurance agency   —   38,951   —       38,951   —  After-tax loss on sale of securities (including impairments)   —   —   (17,859 )     —   (17,859 )Basic EPS   0.70   1.18   0.50       3.29   2.58  Diluted EPS   0.70   1.18   0.50       3.27   2.56  Adjusted diluted EPS (Non-GAAP)(1)   0.73   0.70   0.76       2.76   3.15  Impact to diluted EPS from...

DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) — Veritex Holdings, Inc. (“Veritex”, the “Company”, “we” or “our”) (Nasdaq: VBTX), the holding company for Veritex Community Bank, today announced the results for the fourth quarter and full year of 2024. “We achieved significant milestones during 2024 as we improved our credit risk profile and strengthened and completed our balance sheet remake,” said C. Malcolm Holland, III, the Company’s Chairman and Chief Executive Officer. “My team and I are committed to continue to drive execution of our strategic plan in 2025. Now it’s back to what we do best; grow profitability.” 2024 Highlights:Operating EPS was $2.17 for 2024; Criticized loans decreased approximately $100 million during 2024; Commercial real estate concentrations decreased from 320.2% for the year ended 2023 to 298.9% for the year...

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Ponce Financial Group, Inc., (the “Company”) (NASDAQ: PDLB), the holding company for Ponce Bank (the “Bank”), today announced results for the fourth quarter of 2024. Fourth Quarter 2024 Highlights (Compared to Prior Periods):Net income available to common stockholders was $2.7 million, or $0.12 per diluted share for the three months ended December 31, 2024, as compared to net income available to common stockholders of $2.2 million, or $0.10 per diluted share for the three months ended September 30, 2024 and net income available to common stockholders of $0.5 million, or $0.02 per diluted share for the three months ended December 31, 2023. Total net income for the three months ended December 31, 2024 was $2.9 million. The Company paid dividends of $0.3 million on its preferred stock during...

CHIHUAHUA, Mexico, Jan. 28, 2025 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading supplier and producer of cement and concrete in the United States and Mexico, today announced its results for the fourth quarter and full year of 2024. FY 2024 HIGHLIGHTSConsolidated net sales increased 0.2% year-on-year to US$1,366.7 million U.S. sales grew 3.9% as cement and concrete prices increased 5.5% and 8.1%, respectively Mexico cement and concrete prices increased 4.9% and 6.7%, respectively EBITDA increased 6.2% to US$500.6 million with a 36.6% EBITDA margin Cash and equivalents totaled US$830.6 million Net leverage (net debt/EBITDA) ratio totaled -0.67x as of December 2024 Earnings per share increased 9.5% year-on-year, to US$0.9894 Free cash flow totaled US$321.8 million with a 64.3% free cash flow conversion rate A dividend...